GGrantIndex
Sort

40,608 grants matching prostate cancer

Improving Prostate Cancer Outcome Prediction Through Noninvasive exRNA Assessment

$597,893
Matthew R Cooperberg · University Of California, San Francisco · R01 · FY2020 · CA

Delineating the underlying reasons for the racial disparity in gastric cancer incidence in the United States

$597,836
Meira Epplein · Duke University · R01 · FY2024 · CA

Multifunctional Regulation of Prostate Cancer Metabolism by Sigma1 Modulators

$597,742
Felix Jinhyun Kim · Thomas Jefferson University · R01 · FY2024 · CA

Leveraging DNA damage repair pathways as therapeutic targets in womens cancers

$597,694
Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Cellular impact of X-linked dyskeratosis congenita

$597,620
U Thomas Meier · Albert Einstein College Of Medicine · R01 · FY2019 · HL

Cellular impact of X-linked dyskeratosis congenita

$597,620
U Thomas Meier · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · HL

The Role of Fgf Signaling in Vertebrate Development

$597,615
Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Analysis of drug response in organoids and mouse models

$597,601
Michael M. Shen · Columbia University Health Sciences · R01 · FY2017 · CA

Analysis of drug response in organoids and mouse models

$597,601
Michael M. Shen · Columbia University Health Sciences · R01 · FY2016 · CA

Analysis of drug response in organoids and mouse models

$597,601
Michael M. Shen · Columbia University Health Sciences · R01 · FY2018 · CA

Validation of Biomarkers of Risk for the Early Detection of Lung Cancer

$597,547
Pierre P Massion · Vanderbilt University · U01 · FY2013 · CA

ANDROGEN RECEPTOR BIOCHIPS--PROSTATE CANCER MANAGEMENT

$597,529
Massachusetts Institute Of Technology · R33 · FY2001 · CA

DEFINING THE LINK BETWEEN OBESITY AND THE DEVELOPMENT OF AGGRESSIVE PROSTATE CANCER

$597,521
The Research Foundation For The State University Of New York · · FY2014 · Department of Defense

Telomerase in Development, Senescence and Neoplasia

$597,518
Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA

Phase II Chemoprevention Trial of Selenium and Prostate Cancer

$597,483
Frederick R Ahmann · University Of Arizona · R01 · FY2006 · CA

Prostate Cancer Radio-Pathomics for Differentiating Clinically Significant Disease

$597,465
Peter S Laviolette · Medical College Of Wisconsin · R01 · FY2023 · CA

Smart template for prostate biopsy guidance

$597,435
Jesung Park · Physical Sciences, Inc · R44 · FY2019 · CA

Germline Determinants of Prostate Cancer Evolution

$597,235
Paul Christopher Boutros · University Of California Los Angeles · R01 · FY2024 · CA

Tumor selective inhibition of the WNT pathway

$597,189
Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA

Pharmacological Jak2 inhibition to overcome androgen receptor aberrations in prostate cancer

$597,173
Marja T Nevalainen · Thomas Jefferson University · R01 · FY2025 · CA

Targeting B7-H3 in ovarian cancer

$597,170
Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA

The role of germline and somatic DNA changes at 8q24 in PCa risk

$597,169
Siqun L Zheng · Wake Forest University Health Sciences · R01 · FY2009 · CA

The non-catalytic function of PARP2 in DNA repair and cancer therapy

$597,140
Shan Zha · Columbia University Health Sciences · R01 · FY2022 · CA

A novel flat-panel detector for advanced on-board radiation therapy imaging

$597,140
Ross I. Berbeco · Dana-Farber Cancer Inst · R01 · FY2021 · CA

Early Detection and Diagnosis of Lung Cancer with Endomicroscopy

$597,127
Melissa J Suter · Massachusetts General Hospital · R01 · FY2024 · CA